case_images: PMC10766400_01
case_images: CT scan from November 2021 demonstrating large left adrenal mass and right adrenal mass and right lower lobe mass.
case_images: cro-2024-0017-0001-535195_F01.jpg
case_images: PMC10766400_01_cro-2024-0017-0001-535195_F01.jpg
case_images: F1
case_images: CT-angiography of the chest revealed a 9.2 x 8 x 7.4 cm large heterogeneous hypervascular mass in the right lower lung, a similar-appearing 7.1 x 5.4 x 6.9 cm heterogeneous mass in the left adrenal gland, and a 3.4 cm hypodense mass in the right adrenal gland (shown in Fig. 1, 2).
case_images: CT scan from November 2021 demonstrating large left adrenal mass and right adrenal mass and right lower lobe mass.
case_images: cro-2024-0017-0001-535195_F02.jpg
case_images: PMC10766400_01_cro-2024-0017-0001-535195_F02.jpg
case_images: F2
case_images: CT-angiography of the chest revealed a 9.2 x 8 x 7.4 cm large heterogeneous hypervascular mass in the right lower lung, a similar-appearing 7.1 x 5.4 x 6.9 cm heterogeneous mass in the left adrenal gland, and a 3.4 cm hypodense mass in the right adrenal gland (shown in Fig. 1, 2).
case_images: Ancillary staining from the adrenal mass.
case_images: cro-2024-0017-0001-535195_F03.jpg
case_images: PMC10766400_01_cro-2024-0017-0001-535195_F03.jpg
case_images: F3
case_images: Final pathology identifying the DCTN1-ALK fusion gene.
case_images: cro-2024-0017-0001-535195_F04.jpg
case_images: PMC10766400_01_cro-2024-0017-0001-535195_F04.jpg
case_images: F4
case_images: Next-generation sequencing demonstrated the DCTN1-ALK fusion transcript (Fig. 4).
case_images: PET scan from August 2022 shows left adrenal mass has significantly decreased in size, as well as right lung mass.
case_images: cro-2024-0017-0001-535195_F05.jpg
case_images: PMC10766400_01_cro-2024-0017-0001-535195_F05.jpg
case_images: F5
case_images: Follow-up CT abdomen and pelvis obtained 1 week after starting crizotinib showed a decrease in the size of lung and adrenal masses (shown in Fig. 5, 6), with lung mass now 7.9 x 7.5 cm (previously 8.2 x 8), left adrenal mass now 7.6 x 5.6 (previously 8.2 x 6.2), and right adrenal mass 1.1 x 1.0 cm (previously 3 x 2 cm).
case_images: PET scan from August 2022 shows left adrenal mass has significantly decreased in size, as well as right lung mass.
case_images: cro-2024-0017-0001-535195_F06.jpg
case_images: PMC10766400_01_cro-2024-0017-0001-535195_F06.jpg
case_images: F6
case_images: Follow-up CT abdomen and pelvis obtained 1 week after starting crizotinib showed a decrease in the size of lung and adrenal masses (shown in Fig. 5, 6), with lung mass now 7.9 x 7.5 cm (previously 8.2 x 8), left adrenal mass now 7.6 x 5.6 (previously 8.2 x 6.2), and right adrenal mass 1.1 x 1.0 cm (previously 3 x 2 cm).